SavedAdd your journal

Journals / İstanbul Kuzey Klinikleri / 2017 / Cilt: 4 - Sayı: 1

Integrating personalized genomics into Turkish healthcare system: A cancer-oriented pilot activity of Istanbul Northern Anatolian Public Hospitals with GLAB

Levent DOGANAY
Emrah NİKEREL
Kamil OZDİL
Gizem Dinler DOGANAY
Kemal MEMİSOGLU
Emre KARAKOC
Seyma KATRİNLİ
Pages
1–3
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DOGANAY, L., NİKEREL, E., OZDİL, K., DOGANAY, G. D., MEMİSOGLU, K., KARAKOC, E., KATRİNLİ, S. (2022). Integrating personalized genomics into Turkish healthcare system: A cancer-oriented pilot activity of Istanbul Northern Anatolian Public Hospitals with GLAB. İstanbul Kuzey Klinikleri, Cilt: 4 - Sayı: 1, 1–3. https://ajindex.com/articles/551586

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Forman D, Ferlay J. The Global and Regional Burden of Cancer. In: Stewart BW, Wild CP, editors. World Cancer Report. Lyon: IARCPress; 2014. p. 16-53
  2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1459-544 3. Türkiye İstatistik Kurumu. Ölüm İstatistikleri 2016. Available at: http://www.tuik.gov.tr/PreHaberBultenleri.do?id=21526. Accessed March 12, 2017
  3. Türkiye Halk Sağlığı Kurumu. Türkiye Kanser İstatistikleri 2017. Available at: http://kanser.gov.tr/Dosya/2017Haberler/2014- RAPOR._uzun.pdf. Accessed March 12, 2017
  4. Thomas DM, James PA, Ballinger ML. Clinical implications of genomics for cancer risk genetics. Lancet Oncol 2015;16:e303-8
  5. Lynch HT, Watson P, Conway TA, Lynch JF. Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat 1990;15:63-71
  6. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005;23:276-92
  7. Hartmann LC, Lindor NM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 2016;374:454-68.